Free Trial
LON:TCF

Theracryf (TCF) Share Price, News & Analysis

GBX 0.52 -0.01 (-0.95%)
(As of 06:47 AM ET)

About Theracryf Stock (LON:TCF)

Key Stats

Today's Range
0.52
0.55
50-Day Range
0.50
0.80
52-Week Range
0.49
1.05
Volume
327,031 shs
Average Volume
N/A
Market Capitalization
£2.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders. The company's lead product is SFX-01 that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma and Phase I clinical trials for the treatment of neurodevelopmental disorders, as well as in preclinical stage for the treatment of rhabdomyosarcoma. In addition, it engages in the development of orexin 1 antagonist, which is in late preclinical stage targeting addictive behaviors; orexin 1 antagonist that is in late preclinical stage for the treatment of anxiety; and molecule DAT inhibitor, which is in late preclinical stage targeting fatigue and narcolepsy. The company has a partnership with Stalicla to collaborate on a clinical program in autism spectrum disorder. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Receive TCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theracryf and its competitors with MarketBeat's FREE daily newsletter.

TCF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

TCF Stock Analysis - Frequently Asked Questions

Theracryf's stock was trading at GBX 0.65 at the start of the year. Since then, TCF shares have decreased by 20.0% and is now trading at GBX 0.52.
View the best growth stocks for 2024 here
.

Shares of TCF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Banking
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
£-3,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.24 million
Optionable
N/A
Beta
1.42
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:TCF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners